Head To Head Comparison Of 18f-fch And 18f-psma-1007 Pet/ct In Biochemically Relapsed Prostate Cancer Patients Preliminary Results

被引：0
|
作者：
Witkowska-Patena, E. [1 ,2 ]
Gizewska, A. [1 ,2 ]
Dziuk, M. [1 ,2 ]
Misko, J. [1 ,2 ]
Budzynska, A. [1 ,2 ]
Walecka-Mazur, A. [3 ]
机构：
[1] Mil Inst Med, Warsaw, Poland
[2] Affidea Mazovian PET CT Med Ctr, Warsaw, Poland
[3] Synektik Pharma, Kielce, Poland
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0138
引用
收藏
页码：S446 / S447
页数：2
相关论文
共 50 条
  • [31] Rib Fractures Mimicking Bone Metastases in 18F-PSMA-1007 PET/CT for Prostate Cancer
    Panagiotidis, Emmanouil
    Paschali, Anna
    Giannoula, Evanthia
    Chatzipavlidou, Vasiliki
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (01) : E46 - E48
  • [32] Head-to-Head Comparison of [18F]PSMA-1007 and [18F]FDG PET/CT in Patients with Triple-Negative Breast Cancer
    Andryszak, Natalia
    Swiniuch, Daria
    Wojcik, Elzbieta
    Ramlau, Rodryg
    Ruchala, Marek
    Czepczynski, Rafal
    CANCERS, 2024, 16 (03)
  • [33] Head-to-Head Comparison of [18F]PSMA-1007 and [18F] FDG PET/CT in Patients with Triple-Negative Breast Cancer
    Andryszak, N.
    Swiniuch, D.
    Wojcik, E.
    Ramlau, R.
    Ruchala, M.
    Czepczynski, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S18 - S19
  • [34] 18F-PSMA-1007 multiparametric, dynamic PET/CT in biochemical relapse and progression of prostate cancer
    Sachpekidis, Christos
    Afshar-Oromieh, A.
    Kopka, K.
    Strauss, D. S.
    Pan, L.
    Haberkorn, U.
    Dimitrakopoulou-Strauss, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (03) : 592 - 602
  • [35] Diagnostic value of 18F-PSMA-1007 PET/CT for predicting the pathological grade of prostate cancer
    Niu, Xiao-Bo
    Li, Yan-Peng
    Wang, Jun
    Mei, Xiao-Li
    Zhao, Xue-Yan
    Liu, Ting-Ting
    Xu, Sha-Sha
    Han, Xing-Min
    Cheng, Jing-Liang
    CANCER BIOLOGY & THERAPY, 2024, 25 (01)
  • [36] 18F-FCH PET/CT for patients with uremic hyperparathyroidism
    Xue, Yu
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [37] Ga-68 PSMA-11 VS F-18 PSMA-1007 PET/CT Imaging In Patients With Prostate Cancer: A Head To Head Comparison
    Vangu, M.
    Mbakaza, O.
    Purbhoo, K.
    Momodu, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S499 - S499
  • [38] Feasibility of Different Tumor Delineation Approaches for 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients
    Mittlmeier, Lena M.
    Brendel, Matthias
    Beyer, Leonie
    Albert, Nathalie L.
    Todica, Andrei
    Zacherl, Mathias J.
    Wenter, Vera
    Herlemann, Annika
    Kretschmer, Alexander
    Ledderose, Stephan T.
    Schmidt-Hegemann, Nina-Sophie
    Kunz, Wolfgang G.
    Ricke, Jens
    Bartenstein, Peter
    Ilhan, Harun
    Unterrainer, Marcus
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [39] Evaluation of 18F-PSMA-1007 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy
    Zhou, Xing
    Jiang, Xiao
    Liu, Luzhou
    Wang, Xiaoxiong
    Li, Chuan
    Yao, Yutang
    Kou, Ying
    Shen, Jiaqi
    Shen, Taipeng
    Li, Zeng
    Yang, Shengke
    Zhou, Shukui
    Liao, Hong
    Luo, Zhifu
    Wu, Xiaoai
    Chen, Shirong
    Cheng, Zhuzhong
    TRANSLATIONAL ONCOLOGY, 2022, 15 (01):
  • [40] Non-prostate uptake on 18F-PSMA-1007 PET/CT: a case of myeloma
    Veerasuri, Sowmya
    Redman, Stewart
    Graham, Richard
    Meehan, Chris
    Little, David
    BJR CASE REPORTS, 2021, 7 (02):
12345